Tsha earnings
WebMar 30, 2024 · Net loss for the full-year ended December 31, 2024 was $166 million or $3.78 per share, as compared to a net loss of $174.5 million, or $4.64 per share, for the full-year … WebMar 28, 2024 · This value represents a 68.94% increase compared to the same quarter last year. Zacks Investment Research reports that the 2024 Price to Earnings ratio for TSHA is …
Tsha earnings
Did you know?
WebTaysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2024 Earnings Call Transcript March 28, 2024 Operator: Greetings, and welcome to the Taysha Gene Therapies Fourth Quarter and … WebOn Invalid Date, . Taysha Gene Therapies (NASDAQ: TSHA) reported Q3 2024 earnings per share (EPS) of -$0.64, up 52.59% year over year. Total Taysha Gene Therapies earnings …
WebTaysha Gene Therapies Inc. analyst ratings, historical stock prices, earnings estimates & actuals. TSHA updated stock price target summary. WebHaving purchased US$2.3m worth of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) stock, the recent 12% pullback is not what insiders may have expected. Simply Wall St. Aug-12 …
WebApr 13, 2024 · Check if TSHA Stock has a Buy or Sell Evaluation. TSHA Stock Price (NASDAQ), Forecast, Predictions, ... The upcoming earnings date for Taysha Gene … WebApr 8, 2024 · TSHA Earnings Date and Information. Taysha Gene Therapies has not formally confirmed its next earnings publication date, but the company's estimated earnings date …
WebCurrent and historical p/e ratio for Taysha Gene Therapies (TSHA) from 2024 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the …
WebTSHA Stock Price - Taysha Gene Therapies, Inc.is a patient-centric, clinical-stage gene therapy company, ... The Price-to-Earnings (or P/E) ratio is a commonly used tool for … implications section exampleWebMar 21, 2024 · Taysha Gene Therapies (NASDAQ:TSHA – Get Rating) is scheduled to announce its earnings results after the market closes on Tuesday, March 28th. Analysts … literacy competency testWebMar 21, 2024 · With Taysha Gene Therapies stock trading at $0.71 per share, the total value of Taysha Gene Therapies stock (market capitalization) is $44.58M. Taysha Gene Therapies stock was originally listed at a price of $24.06 in Sep 24, 2024. If you had invested in Taysha Gene Therapies stock at $24.06, your return over the last 2 years would have been ... literacy competencyWeb12 hours ago · Analysts predict earnings falling 19% to 86 cents per share with revenue growing 27% to $23.78 billion in Q1. Wall Street forecasts gross margins around 21% in the current quarter. implications social workWebMar 31, 2024 · Net loss for the full year ended December 31, 2024, was $174.5 million or $4.64 per share, compared to a net loss of $60 million or $3.40 per share for the full year … literacy comprehensionWebTSHA earnings history information, presented by NextEarningsDate.com. Period Earnings Date GAAP; Q3 2024: 11/8/2024-0.640: Q2 2024: 8/11/2024-0.840: Q1 2024 literacy componentsWebApr 14, 2024 · TSHA – 3:00 p.m. Cassian – 4:30 p.m. Sasha & Digweek 6:00 p.m. Camelphat – 7:30 p.m. ... which emphasizes earnings estimates and estimate revisions to find great stocks. implications syn